Cite
Bame E, Tang H, Burns JC, et al. Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Clin Transl Immunology. 2021;10(6):e1295doi: 10.1002/cti2.1295.
Bame, E., Tang, H., Burns, J. C., Arefayene, M., Michelsen, K., Ma, B., Marx, I., Prince, R., Roach, A. M., Poreci, U., Donaldson, D., Cullen, P., Casey, F., Zhu, J., Carlile, T. M., Sangurdekar, D., Zhang, B., Trapa, P., Santoro, J., Muragan, P., Pellerin, A., Rubino, S., Gianni, D., Bajrami, B., Peng, X., Coppell, A., Riester, K., Belachew, S., Mehta, D., Palte, M., Hopkins, B. T., Scaramozza, M., Franchimont, N., & Mingueneau, M. (2021). Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Clinical & translational immunology, 10(6), e1295. https://doi.org/10.1002/cti2.1295
Bame, Eris, et al. "Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells." Clinical & translational immunology vol. 10,6 (2021): e1295. doi: https://doi.org/10.1002/cti2.1295
Bame E, Tang H, Burns JC, Arefayene M, Michelsen K, Ma B, Marx I, Prince R, Roach AM, Poreci U, Donaldson D, Cullen P, Casey F, Zhu J, Carlile TM, Sangurdekar D, Zhang B, Trapa P, Santoro J, Muragan P, Pellerin A, Rubino S, Gianni D, Bajrami B, Peng X, Coppell A, Riester K, Belachew S, Mehta D, Palte M, Hopkins BT, Scaramozza M, Franchimont N, Mingueneau M. Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Clin Transl Immunology. 2021 Jun 14;10(6):e1295. doi: 10.1002/cti2.1295. eCollection 2021. PMID: 34141433; PMCID: PMC8204096.
Copy
Download .nbib